Author Topic: (Abst.) Ocrelizumab in highly disabled progressive MS patients  (Read 14 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Ocrelizumab in highly disabled progressive MS patients
« on: January 07, 2024, 08:02:50 am »

From PubMed (January 7, 2024)--"Ocrelizumab in highly disabled progressive multiple sclerosis patients":

https://pubmed.ncbi.nlm.nih.gov/38181693/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
457 Views
Last post December 26, 2016, 02:47:31 pm
by agate
0 Replies
102 Views
Last post June 11, 2018, 07:48:30 pm
by agate
0 Replies
29 Views
Last post November 02, 2021, 08:50:24 pm
by agate
0 Replies
36 Views
Last post February 16, 2022, 08:41:56 pm
by agate
0 Replies
30 Views
Last post December 13, 2022, 03:12:39 pm
by agate